Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paractin in Relapsing Remitting Multiple Sclerosis
NCT02280876Phase 2Completed
- Sponsor
- Universidad Austral de Chile
- Start
- Jan 2012
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of andrographis paniculata extract in relapsing-remitting multiple sclerosis (RRMS), sponsored by Universidad Austral de Chile. Started Jan 2012; status: completed.
02
Drugs
andrographis paniculata extract
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT02280876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02280876.